Reduced insulin sensitivity, impaired postprandial glucagon regulation, and declining hepatic and renal function may lead to inaccurate insulin dose recommendations, increasing the risk of cumulative hypoglycemia. This evidence concerns the gene INS and Hypoglycemia.